Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2005;46:943-947
Published online before print August 8, 2005, doi: 10.1161/01.HYP.0000174602.59935.d5
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
46/4/943    most recent
01.HYP.0000174602.59935.d5v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bolterman, R. J.
Right arrow Articles by Romero, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bolterman, R. J.
Right arrow Articles by Romero, J. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Blood Pressure Medicines
*High Blood Pressure
Hazardous Substances DB
*CAPTOPRIL

(Hypertension. 2005;46:943.)
© 2005 American Heart Association, Inc.


Part 2 Original Articles

Effects of Captopril on the Renin Angiotensin System, Oxidative Stress, and Endothelin in Normal and Hypertensive Rats

Rodney J. Bolterman; Melissa C. Manriquez; M. Clara Ortiz Ruiz; Luis A. Juncos; J. Carlos Romero

From Department of Physiology and Biomedical Engineering (R.J.B., J.C.R.), Mayo Clinic College of Medicine, Rochester, Minn; Div. of Nephrology and Hypertension (M.C.M., L.A.J.), Mayo Clinic College of Medicine, Rochester, Minn; Department of Physiology (M.C.O.R.), University of Murcia, Murcia, Spain.

Correspondence to J. Carlos Romero, MD, Professor of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905. E-mail romero.juan{at}mayo.edu

There is substantial evidence suggesting that angiotensin II plays an important role in elevating blood pressure of spontaneously hypertensive rats, despite normal plasma renin activity, and that converting enzyme inhibitors (captopril) can effectively normalize blood pressure in the spontaneously hypertensive rats. One mechanism by which angiotensin II induces hypertension is via oxidative stress and endothelin, as seen in subpressor angiotensin II–induced hypertension. In fact, it has been shown that antioxidants lower mean arterial pressure in spontaneously hypertensive rats. However, the relationship between angiotensin II, oxidative stress, and endothelin in the spontaneously hypertensive rats is still relatively undefined. This study examines the relationship between mean arterial pressure, plasma renin activity, angiotensin II, oxidative stress, and endothelin in spontaneously hypertensive rats compared with normotensive Wistar Kyoto rats, and the effects of captopril on this association. Untreated spontaneously hypertensive rats had increased plasma angiotensin II levels despite normal plasma renin activity, oxidative stress, and endothelin. Captopril treatment in spontaneously hypertensive rats lowered mean arterial pressure, angiotensin II, oxidative stress, and endothelin, and increased plasma renin activity. In contrast, captopril increased plasma renin activity (suggesting effective captopril treatment) but did not significantly alter mean arterial pressure, angiotensin II, oxidative stress, or endothelin of Wistar Kyoto rats. These results suggest that in spontaneously hypertensive rats, angiotensin II is a primary instigator of hypertension, and that captopril selectively lowers angiotensin II, oxidant stress, and endothelin, which in turn may contribute to the blood pressure-lowering efficacy of captopril in spontaneously hypertensive rats.


Key Words: angiotensin II • angiotensin-converting enzyme inhibitors • captopril • endothelin • oxidative stress • rats, spontaneously hypertensive




This article has been cited by other articles:


Home page
Circ Heart FailHome page
A. Garnier, J. Zoll, D. Fortin, B. N'Guessan, F. Lefebvre, B. Geny, B. Mettauer, V. Veksler, and R. Ventura-Clapier
Control by Circulating Factors of Mitochondrial Function and Transcription Cascade in Heart Failure: A Role for Endothelin-1 and Angiotensin II
Circ Heart Fail, July 1, 2009; 2(4): 342 - 350.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
H. Li, W. Han, V. A. M. Villar, L. B. Keever, Q. Lu, U. Hopfer, M. T. Quinn, R. A. Felder, P. A. Jose, and P. Yu
D1-Like Receptors Regulate NADPH Oxidase Activity and Subunit Expression in Lipid Raft Microdomains of Renal Proximal Tubule Cells
Hypertension, June 1, 2009; 53(6): 1054 - 1061.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. J. Welch
Angiotensin II-Dependent Superoxide: Effects on Hypertension and Vascular Dysfunction
Hypertension, July 1, 2008; 52(1): 51 - 56.
[Full Text] [PDF]


Home page
StrokeHome page
J. S. Smeda and J. J. McGuire
Effects of Poststroke Losartan Versus Captopril Treatment on Myogenic and Endothelial Function in the Cerebrovasculature of SHRsp
Stroke, May 1, 2007; 38(5): 1590 - 1596.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. J. Miller, L. E. Norton, M. P. Murphy, M. C. Dalsing, and J. L. Unthank
The role of the renin-angiotensin system and oxidative stress in spontaneously hypertensive rat mesenteric collateral growth impairment
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2523 - H2531.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. Meier, J. Rossert, P.-F. Plouin, and M. Burnier
Atherosclerotic renovascular disease: beyond the renal artery stenosis
Nephrol. Dial. Transplant., April 1, 2007; 22(4): 1002 - 1006.
[Full Text] [PDF]


Home page
CirculationHome page
J. M. Zimmet and J. M. Hare
Nitroso-Redox Interactions in the Cardiovascular System
Circulation, October 3, 2006; 114(14): 1531 - 1544.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Feletou and P. M. Vanhoutte
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. A. F. De Godoy and S. Rattan
Angiotensin-Converting Enzyme and Angiotensin II Receptor Subtype 1 Inhibitors Restitute Hypertensive Internal Anal Sphincter in the Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 725 - 734.
[Abstract] [Full Text] [PDF]